Heart Failure Clinical Trial

BAY58-2667 Dose Finding Trial Investigating Fixed Doses in Patients With Acute Decompensated Chronic Congestive Heart Failure (ADHF)

Summary

A placebo controlled, double-blind and randomized study to assess different doses of a new drug (BAY58-2667) given intravenously, to evaluate if it is safe and can help to improve the well-being of patients with acute decompensated heart failure.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Male and non-pregnant, non-lactating female subjects, age >/= 18 years of age; or women without childbearing potential defined as postmenopausal women aged 55 years or older, women with bilateral tubal ligation, women with bilateral ovariectomy, and women with a hysterectomy
Subjects must have the clinical diagnosis of CHF made at least three months prior to enrollment

Subjects must experience worsening of both of the symptoms below leading to hospitalization at the time of entry into the study:

dyspnea and
clinical evidence of volume overload

Exclusion Criteria:

Acute de-novo heart failure
Acute myocardial infarction and/or myocardial infarction within 30 days
Valvular heart disease requiring surgical intervention during the course of the study
Heart failure due to or associated with uncorrected primary valvular disease, malfunctioning artificial heart valve, or uncorrected congenital heart disease
Primary hypertrophic cardiomyopathy
Acute inflammatory heart disease, eg, acute myocarditis
Unstable angina requiring angiography

Study is for people with:

Heart Failure

Phase:

Phase 2

Estimated Enrollment:

12

Study ID:

NCT01065077

Recruitment Status:

Terminated

Sponsor:

Bayer

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 58 Locations for this study

See Locations Near You


Ridgewood New Jersey, 07450, United States

Winston-Salem North Carolina, 27157, United States

Cleveland Ohio, 44106, United States

Fairfield Ohio, 45014, United States

Philadelphia Pennsylvania, 19102, United States

Philadelphia Pennsylvania, 19107, United States

Linz Oberösterreich, 4010, Austria

Wien , 1090, Austria

Zagreb , 10000, Croatia

Helsinki , 00029, Finland

Oulu , 90220, Finland

Greifswald Mecklenburg-Vorpommern, 17475, Germany

Köln Nordrhein-Westfalen, 50924, Germany

Homburg Saarland, 66424, Germany

Erfurt Thüringen, 99089, Germany

Jena Thüringen, 07740, Germany

Haifa , 34362, Israel

Jerusalem , 91120, Israel

Tiberias , 31905, Israel

San Fermo della Battaglia Como, 22020, Italy

Brescia , 25100, Italy

Ferrara , 44100, Italy

Mantova , 46100, Italy

Torino , 10126, Italy

Nagoya Aichi, 460-0, Japan

Kure Hiroshima, 737-0, Japan

Higashiibaraki Ibaraki, 311-3, Japan

Kawasaki Kanagawa, 216-8, Japan

Omura Nagasaki, 856-8, Japan

Bunkyo-ku Tokyo, 113-8, Japan

Shinagawa Tokyo, 142-8, Japan

Osaka , 543-0, Japan

Gdansk , 80-21, Poland

Lodz , 91-34, Poland

Warszawa , 02-50, Poland

Warszawa , 04-62, Poland

Wroclaw , 50-98, Poland

Zabrze , 41-80, Poland

Zgorzelec , 59-90, Poland

Bucharest , 02232, Romania

Cluj-Napoca , 40000, Romania

Krasnoyarsk , 66002, Russian Federation

Moscow , 10926, Russian Federation

Moscow , 11509, Russian Federation

Moscow , 11988, Russian Federation

Beograd , 11000, Serbia

Nis , 18000, Serbia

Sremska Kamenica , 21204, Serbia

Lucenec , 984 3, Slovakia

Martin , 036 5, Slovakia

Celje , 3000, Slovenia

Golnik , 4204, Slovenia

Ljubljana , 1000, Slovenia

Göteborg , 413 4, Sweden

Uppsala , 751 8, Sweden

Lugano Ticino, 6900, Switzerland

Zürich , 8091, Switzerland

Bangkok , 10400, Thailand

How clear is this clinincal trial information?

Study is for people with:

Heart Failure

Phase:

Phase 2

Estimated Enrollment:

12

Study ID:

NCT01065077

Recruitment Status:

Terminated

Sponsor:


Bayer

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider